Is there a prognostic role for C-reactive protein in ischemic stroke?

Acta Neurologica Scandinavica

Volumn 122, Issue 3, 2010, Pages 209-216

  Corso, G ^a   Bottacchi, E ^a   Brusa, A ^a   Di Benedetto, M D ^a   Giardini, G ^a   Lia, C ^a   Reggiani, M ^a   Veronese Morosini, M ^a  

^a Ospedale Regionale   (Italy)

Author keywords

CRP; ischemic stroke; prognosis

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; FATALITY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS;

AGED; C-REACTIVE PROTEIN; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; ROC CURVE; STROKE;

EID: 77955293649     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01288.x     Document Type: Article

References (30)

1. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-Reactive protein and outcome after ischemic stroke. Stroke 1999 30 : 981 985.
2. Rost NS, Wolf PA, Kase CS et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack. The Framingham study. Stroke 2001 32 : 2575 2579.
3. Di Napoli M, Papa F, for the Villa Pini Stroke Data Bank Investigators. Inflammation, hemostatic markers and antithrombotic agents in relation to long term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke 2002 33 : 1763 1771.
4. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurement after first ischemic stroke. Stroke 2002 33 : 2459 2464.
5. Arenillas JF, Alvarez-Sabin J, Molian CA et al. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003 34 : 2463 2470.
6. Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease controls and prevention and the American Heart Association. Circulation 2003 107 : 499 511.
7. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 2004 109 : 1955 1959.
8. Di Napoli M, Scwhaninger M, Cappelli R et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke. Stroke 2005 36 : 1316 1329.
9. Corso G, Bottacchi E, Giardini G et al. Community-based study of stroke incidence in the Valley of Aosta, Italy. Neuroepidemiol 2009 32 : 186 195.
10. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976 54 : 451 453.
11. Lovett JK, Coull A, Rothwell PM, on behalf of the Oxford Vascular Study. Early risk of recurrent stroke by aetiological subtype: implications for stroke prevention. Neurology 2004 62 : 569 574.
12. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988 19 : 604 607.
13. Brott T, Adams HP Jr., Olinger CP et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989 20 : 864 870. (Pubitemid 19188240)
14. Mahoney FY, Barthel D. Functional evaluation: Barthel index. Md State Med J. 1965 14 : 56 61.
15. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991 337 : 1521 1526.
16. Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, for the TOAST investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993 24 : 35 41.
17. Elkind MS, Coates K, Tai W, Paik MC, Boden-Albala B, Sacco RL. Levels of acute phase proteins remain stable after ischemic stroke. BMC Neurol 2006 6 : 37.
18. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001 32 : 917 924.
19. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001 32 : 133 138. (Pubitemid 32063837)
20. Purroy F, Montaner J, Molina CA et al. C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand 2007 115 : 60 66.
21. Shantikumar S, Grant PJ, Catto AJ, Bamford JM, Carter AM. Relationship with markers of endothelial cell and platelet activation. Elevated C-reactive protein and long-term mortality after ischemic stroke. Stroke 2009 40 : 977 979.
22. Smith SC, Anderson JL, Cannon RO et al. CDC/AHA Workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice report from the clinical practice discussion group. Circulation 2004 110 : e550 53.
23. Jialal I, Devaraj S, Venugopal SK. C-Reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004 44 : 6 11.
24. Dandona P. Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein. Mayo Clin Proc 2008 83 : 333 342.
25. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008 359 : 2195 2192.
26. Kennon S, Price CP, Mills PG et al. The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. J Am Coll Cardiol 2001 37 : 1266 1270.
27. Ridker PM, Cannon CP, Morrow D et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005 352 : 20 28.
28. Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first ever ischemic stroke. Stroke 2003 34 : 2922 2929.
29. Despres J-P. CRP and risk of coronary heart disease: can exercise training cool down the flames? Arterioscler Thromb Vasc Biol 2004 24 : 1743 1745.
30. Okita K, Nishijma H, Murakami T et al. Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 2004 24 : 1868 1873.